These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 20102884

  • 1. Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial).
    McBane RD, Hardison RM, Sobel BE, BARI 2D Study Group.
    Am J Cardiol; 2010 Jan 01; 105(1):17-24. PubMed ID: 20102884
    [Abstract] [Full Text] [Related]

  • 2. Profibrinolytic, antithrombotic, and antiinflammatory effects of an insulin-sensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.
    Sobel BE, Hardison RM, Genuth S, Brooks MM, McBane RD, Schneider DJ, Pratley RE, Huber K, Wolk R, Krishnaswami A, Frye RL, BARI 2D Investigators.
    Circulation; 2011 Aug 09; 124(6):695-703. PubMed ID: 21768545
    [Abstract] [Full Text] [Related]

  • 3. Type 2 Diabetes and Cardiovascular Factors Contrasted with Fibrinolysis Disorders in the Blood of Patients with Peripheral Arterial Disease.
    Wieczór R, Wieczór AM, Kulwas A, Rość D.
    Medicina (Kaunas); 2019 Jul 22; 55(7):. PubMed ID: 31336615
    [Abstract] [Full Text] [Related]

  • 4. Thrombotic/Thrombolytic Balance as a Cardiac Treatment Determinant in Patients With Diabetes Mellitus and Coronary Artery Disease.
    Tsujimoto T, Kajio H.
    J Am Heart Assoc; 2019 Jan 22; 8(2):e011207. PubMed ID: 30646801
    [Abstract] [Full Text] [Related]

  • 5. Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: association with increased plasminogen activator inhibitor-1.
    Aso Y, Matsumoto S, Fujiwara Y, Tayama K, Inukai T, Takemura Y.
    Metabolism; 2002 Apr 22; 51(4):471-6. PubMed ID: 11912556
    [Abstract] [Full Text] [Related]

  • 6. [Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy].
    Zalewska-Rydzkowska D, Rość D, Ponikowska I, Michalski A, Graczykowska-Koczorowska A, Rydzkowski M.
    Pol Merkur Lekarski; 2001 Nov 22; 11(65):414-7. PubMed ID: 11852811
    [Abstract] [Full Text] [Related]

  • 7. [Evolution of fibrinolysis status with D-dimer level and the rate of plasminogen activator inhibitor type-1/D-dimer in acute coronary syndrome patients complicated with impaired glucose tolerance].
    Wu WD, Xu YH, Tan PY.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Aug 22; 15(8):472-5. PubMed ID: 12919647
    [Abstract] [Full Text] [Related]

  • 8. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
    van der Bom JG, Bots ML, Haverkate F, Meyer P, Hofman A, Grobbee DE, Kluft C.
    Thromb Haemost; 1999 Feb 22; 81(2):275-80. PubMed ID: 10064006
    [Abstract] [Full Text] [Related]

  • 9. [Levels of tissue-type plasminogen activator (T-PA), its inhibitor (PAI-1) and fibrinogen in the blood of patients with type 1 and 2 diabetes mellitus].
    Kvasnicka J, Skrha J, Perusicová J, Maslowská H, Pochopová L.
    Cas Lek Cesk; 1996 Mar 20; 135(6):174-7. PubMed ID: 8681360
    [Abstract] [Full Text] [Related]

  • 10. Increased Hazard of Myocardial Infarction With Insulin-Provision Therapy in Actively Smoking Patients With Diabetes Mellitus and Stable Ischemic Heart Disease: The BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) Trial.
    Khan AA, Chung MJ, Novak E, Brown DL.
    J Am Heart Assoc; 2017 Sep 13; 6(9):. PubMed ID: 28903941
    [Abstract] [Full Text] [Related]

  • 11. Physical activity status and adverse age-related differences in coagulation and fibrinolytic factors in women.
    DeSouza CA, Jones PP, Seals DR.
    Arterioscler Thromb Vasc Biol; 1998 Mar 13; 18(3):362-8. PubMed ID: 9514404
    [Abstract] [Full Text] [Related]

  • 12. Metabolic factors, adipose tissue, and plasminogen activator inhibitor-1 levels in type 2 diabetes: findings from the look AHEAD study.
    Belalcazar LM, Ballantyne CM, Lang W, Haffner SM, Rushing J, Schwenke DC, Pi-Sunyer FX, Tracy RP, Look Action for Health in Diabetes Research Group.
    Arterioscler Thromb Vasc Biol; 2011 Jul 13; 31(7):1689-95. PubMed ID: 21512162
    [Abstract] [Full Text] [Related]

  • 13. Prospective double-arm study of fibrinolysis in surgical patients.
    Kosir MA, Schmittinger L, Barno-Winarski L, Duddella P, Pone M, Perales A, Lange P, Brish LK, McGee K, Beleski K, Pawlak J, Mammen E, Sajahan NP, Kozol RA.
    J Surg Res; 1998 Jan 13; 74(1):96-101. PubMed ID: 9536981
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
    Konieczynska M, Fil K, Bazanek M, Undas A.
    Thromb Haemost; 2014 Apr 01; 111(4):685-93. PubMed ID: 24306139
    [Abstract] [Full Text] [Related]

  • 17. Plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are correlated with the presence of transplant coronary artery disease in cardiac transplant recipients.
    Warshofsky MK, Wasserman HS, Wang W, Teng P, Sciacca R, Apfelbaum M, Schwartz A, Michler RE, Mancini DM, Cannon PJ, Rabbani LE.
    Am J Cardiol; 1997 Jul 15; 80(2):145-9. PubMed ID: 9230149
    [Abstract] [Full Text] [Related]

  • 18. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
    Lahlou-Laforet K, Alhenc-Gelas M, Pornin M, Bydlowski S, Seigneur E, Benetos A, Kierzin JM, Scarabin PY, Ducimetiere P, Aiach M, Guize L, Consoli SM.
    Am J Cardiol; 2006 May 01; 97(9):1287-91. PubMed ID: 16635597
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction.
    Tataru MC, Heinrich J, Junker R, Schulte H, von Eckardstein A, Assmann G, Koehler E.
    Eur Heart J; 1999 Oct 01; 20(20):1493-502. PubMed ID: 10493848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.